140 related articles for article (PubMed ID: 25438883)
21. Development of antimycobacterial tetrahydrothieno[2,3-c]pyridine-3-carboxamides and hexahydrocycloocta[b]thiophene-3-carboxamides: Molecular modification from known antimycobacterial lead.
Nallangi R; Samala G; Sridevi JP; Yogeeswari P; Sriram D
Eur J Med Chem; 2014 Apr; 76():110-7. PubMed ID: 24583350
[TBL] [Abstract][Full Text] [Related]
22.
Juhás M; Kučerová L; Horáček O; Janďourek O; Kubíček V; Konečná K; Kučera R; Bárta P; Janoušek J; Paterová P; Kuneš J; Doležal M; Zitko J
Molecules; 2020 Mar; 25(7):. PubMed ID: 32230728
[TBL] [Abstract][Full Text] [Related]
23. Synthesis, antimycobacterial and antifungal evaluation of 3-arylaminopyrazine-2,5-dicarbonitriles.
Palek L; Dvorák J; Svobodová M; Buchta V; Jampílek J; Dolezal M
Arch Pharm (Weinheim); 2008 Jan; 341(1):61-5. PubMed ID: 18072243
[TBL] [Abstract][Full Text] [Related]
24. Design, synthesis and biological activity of pyrazinamide derivatives for anti-Mycobacterium tuberculosis.
Zhou S; Yang S; Huang G
J Enzyme Inhib Med Chem; 2017 Dec; 32(1):1183-1186. PubMed ID: 28870094
[TBL] [Abstract][Full Text] [Related]
25. Synthesis and antimycobacterial activity of pyrazine and quinoxaline derivatives.
Seitz LE; Suling WJ; Reynolds RC
J Med Chem; 2002 Dec; 45(25):5604-6. PubMed ID: 12459027
[TBL] [Abstract][Full Text] [Related]
26. Synthesis, in vitro and in vivo antimycobacterial activities of diclofenac acid hydrazones and amides.
Sriram D; Yogeeswari P; Devakaram RV
Bioorg Med Chem; 2006 May; 14(9):3113-8. PubMed ID: 16412646
[TBL] [Abstract][Full Text] [Related]
27. Lipophilic pyrazinoic acid amide and ester prodrugs stability, activation and activity against M. tuberculosis.
Simões MF; Valente E; Gómez MJ; Anes E; Constantino L
Eur J Pharm Sci; 2009 Jun; 37(3-4):257-63. PubMed ID: 19491013
[TBL] [Abstract][Full Text] [Related]
28. Synthesis, antimycobacterial and antifungal evaluation of some new 1-ethyl-5-(hetero)aryl-6-styryl-1,6-dihydropyrazine-2,3-dicarbonitriles.
Verbitskiy EV; Slepukhin PA; Kravchenko MA; Skornyakov SN; Evstigneeva NP; Kungurov NV; Zil'berberg NV; Rusinov GL; Chupakhin ON; Charushin VN
Bioorg Med Chem Lett; 2015 Feb; 25(3):524-8. PubMed ID: 25556103
[TBL] [Abstract][Full Text] [Related]
29. Synthesis and structure activity relationship of imidazo[1,2-a]pyridine-8-carboxamides as a novel antimycobacterial lead series.
Ramachandran S; Panda M; Mukherjee K; Choudhury NR; Tantry SJ; Kedari CK; Ramachandran V; Sharma S; Ramya VK; Guptha S; Sambandamurthy VK
Bioorg Med Chem Lett; 2013 Sep; 23(17):4996-5001. PubMed ID: 23867166
[TBL] [Abstract][Full Text] [Related]
30. Synthesis, characterization and in vitro biological evaluation of some novel 1,3,5-triazine-Schiff base conjugates as potential antimycobacterial agents.
Avupati VR; Yejella RP; Parala VR; Killari KN; Papasani VM; Cheepurupalli P; Gavalapu VR; Boddeda B
Bioorg Med Chem Lett; 2013 Nov; 23(21):5968-70. PubMed ID: 24044875
[TBL] [Abstract][Full Text] [Related]
31. Identification and development of 2-methylimidazo[1,2-a]pyridine-3-carboxamides as Mycobacterium tuberculosis pantothenate synthetase inhibitors.
Samala G; Nallangi R; Devi PB; Saxena S; Yadav R; Sridevi JP; Yogeeswari P; Sriram D
Bioorg Med Chem; 2014 Aug; 22(15):4223-32. PubMed ID: 24953948
[TBL] [Abstract][Full Text] [Related]
32. Lipophilic N-acylpyrazinamide derivatives: synthesis, physicochemical characterization, liposome incorporation, and in vitro activity against Mycobacterium avium-intracellulare.
Liu ZZ; Guo XD; Straub LE; Erdos G; Prankerd RJ; Gonzalez-Rothi RJ; Schreier H
Drug Des Discov; 1991 Nov; 8(1):57-67. PubMed ID: 1810412
[TBL] [Abstract][Full Text] [Related]
33. [In vitro antimycobacterial activities of pyrazinamide analogs: results of screening tests].
Yamamoto S; Toida I; Watanabe N; Ura T
Kekkaku; 1996 Mar; 71(3):253-8. PubMed ID: 8901227
[TBL] [Abstract][Full Text] [Related]
34. Antimycobacterial activity of a series of pyrazinoic acid esters.
Cynamon MH; Klemens SP; Chou TS; Gimi RH; Welch JT
J Med Chem; 1992 Apr; 35(7):1212-5. PubMed ID: 1560435
[TBL] [Abstract][Full Text] [Related]
35. Thienopyrimidines as novel inhibitors of Mycobacterium tuberculosis: synthesis and in-vitro studies.
Rashmi P; Nargund LV; Hazra K; Chandra JN
Arch Pharm (Weinheim); 2011 Jul; 344(7):459-65. PubMed ID: 21598298
[TBL] [Abstract][Full Text] [Related]
36. Design, synthesis and antimycobacterial evaluation of novel 3-substituted-N-aryl-6,7-dimethoxy-3a,4-dihydro-3H-indeno[1,2-c]pyrazole-2-carboxamide analogues.
Ahsan MJ; Samy JG; Dutt KR; Agrawal UK; Yadav BS; Vyas S; Kaur R; Yadav G
Bioorg Med Chem Lett; 2011 Aug; 21(15):4451-3. PubMed ID: 21733688
[TBL] [Abstract][Full Text] [Related]
37. Synthesis of pyrazinamide Mannich bases and its antitubercular properties.
Sriram D; Yogeeswari P; Reddy SP
Bioorg Med Chem Lett; 2006 Apr; 16(8):2113-6. PubMed ID: 16464574
[TBL] [Abstract][Full Text] [Related]
38. Derivatives of 3-Aminopyrazine-2-carboxamides: Synthesis, Antimicrobial Evaluation, and in Vitro Cytotoxicity.
Bouz G; Semelková L; Janďourek O; Konečná K; Paterová P; Navrátilová L; Kubíček V; Kuneš J; Doležal M; Zitko J
Molecules; 2019 Mar; 24(7):. PubMed ID: 30925695
[TBL] [Abstract][Full Text] [Related]
39. Synthesis, antimycobacterial and cytotoxic activity of α,β-unsaturated amides and 2,4-disubstituted oxazoline derivatives.
Avalos-Alanís FG; Hernández-Fernández E; Carranza-Rosales P; López-Cortina S; Hernández-Fernández J; Ordóñez M; Guzmán-Delgado NE; Morales-Vargas A; Velázquez-Moreno VM; Santiago-Mauricio MG
Bioorg Med Chem Lett; 2017 Feb; 27(4):821-825. PubMed ID: 28117200
[TBL] [Abstract][Full Text] [Related]
40. Synthesis and antimycobacterial properties of ring-substituted 6-hydroxynaphthalene-2-carboxanilides.
Kos J; Nevin E; Soral M; Kushkevych I; Gonec T; Bobal P; Kollar P; Coffey A; O'Mahony J; Liptaj T; Kralova K; Jampilek J
Bioorg Med Chem; 2015 May; 23(9):2035-43. PubMed ID: 25819330
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
